[Ip-health] Trade Talk Documents Suggest Access to Medicines May Become Harder

Peter Maybarduk pmaybarduk at citizen.org
Thu Oct 16 05:20:22 PDT 2014

Please note this article has been updated as follows: 


"Although the U.S. trade rep never publicly confirmed its negotiating position, the specter of 12 years of exclusivity has riled consumer groups. Last year, more than a dozen groups, including AARP and Consumers Union, wrote the White House over concerns expensive biologics will be out of reach for many Americans.

"They also noted the White House budget regularly seeks a 7-year exclusivity period. “This [shorter exclusivity period] would be better than the status quo, but still impose needless costs on the system and suffering on U.S. citizens,” says Peter Maybarduk, who heads the Global Access to Medicines Campaign at Public Citizen, a consumer advocacy group, who has reviewed the document. “But this leak shows us that the White House is playing a dangerous game: in this secretive negotiation, the Administration is pressing for the longer 12-year period and is surrendering that budget pledge.”

More information about the Ip-health mailing list